Pomerantz Launches Securities Investigation Into First Citizens BancShares

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Pomerantz investigates First Citizens BancShares for potential securities fraud following disappointing Q4 earnings and weak guidance, triggering an 8.49% stock decline.

Pomerantz Launches Securities Investigation Into First Citizens BancShares

Pomerantz LLP has initiated an investigation into potential securities fraud claims against First Citizens BancShares, Inc. (FCNCA) following the company's fourth-quarter 2025 earnings report. The investigation centers on allegations that the bank may have misrepresented or failed to disclose material information regarding its financial performance and operational efficiency to investors.

First Citizens BancShares reported an efficiency ratio of 64.5% for Q4 2025, falling short of analyst expectations and signaling higher-than-anticipated operating costs relative to revenue generation. Additionally, the company issued a weaker-than-expected outlook for future revenue and net interest income, citing challenging operating conditions. The disappointing guidance prompted a sharp market reaction, with the stock declining 8.49% following the announcement.

Investors who purchased FCNCA shares during the relevant period and sustained losses are encouraged to contact the firm. Such investigations are typically initiated when significant earnings misses or guidance cuts raise questions about the timeliness and accuracy of prior disclosures made to the investment community.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 17

Related Coverage

GlobeNewswire Inc.

uniQure, Gartner Face Securities Fraud Suits Over Material Disclosure Failures

Law firm files class actions against uniQure, Gartner, and Trip.com for alleged failure to disclose material information. Stock declines range from 19% to 49%.

QUREITTCOM
GlobeNewswire Inc.

Trip.com Faces Securities Fraud Lawsuit After Antitrust Probe, Stock Slides 19%

Trip.com faces securities fraud lawsuit after Chinese antitrust probe alleges monopolistic practices; stock fell 19.4%. Investors have until May 11, 2026 to file claims.

TCOM
GlobeNewswire Inc.

Gartner Faces Securities Fraud Suit After 48% Stock Plunge on Guidance Miss

Gartner faces securities fraud suit after 48% stock decline linked to reduced guidance. Investors can apply as lead plaintiffs through Kahn Swick & Foti, LLC.

QURETCOM
GlobeNewswire Inc.

Driven Brands Faces Securities Fraud Suit Over Misstated Financials, Stock Plummets 39%

Driven Brands Holdings faces securities fraud class action over undisclosed financial statement errors spanning 2023-2025, triggering a 39% stock decline.

QUREDRVNTCOM
GlobeNewswire Inc.

Apollo Global Management Hit with Securities Fraud Suit Over Epstein Ties, 16% Stock Plunge

Apollo Global Management faces securities fraud class action over undisclosed Epstein communications. Stock fell 16% during class period; investors can file claims by May 1, 2026.

APOAPOSAPOpA
GlobeNewswire Inc.

Corcept Therapeutics Faces Securities Fraud Suit Over Undisclosed FDA Setback

Class action lawsuit filed against Corcept Therapeutics alleging securities fraud tied to FDA rejection of relacorilant, triggering 50% stock plunge.

CORTQURETCOM